JPMorgan analyst Lisa C. Gill maintained a Neutral rating on Teladoc Health, Inc TDOC on Thursday with a price target of $9, down from the prior $11.On April 30, Teladoc reported first-quarter revenue of $629.4 million, down 3%, beating the consensus estimate of $619.29 million. The company reported a first-quarter loss of 53 cents per share, missing analyst estimates for a loss of 34 cents per share.Also Read: Teladoc Health Partners With Eli Liily’s LillyDirect to Expand Access to Zepbound For Weight Loss ...

Virtual healthcare services, or telehealth, are rapidly becoming a standard of care in the expanding digital healthcare space. This is bringing a new class of tech-driven innovators to the forefront. Hims & Hers Health, Inc. (HIMS) and Teladoc Health, Inc. (TDOC) stand out as emerging players in the rapidly evolving digital health space, providing remote consultations and health management solutions to consumers.Hims & Hers is a consumer-first platform transforming the way customers fulfill their health and ...